Lessons learned 1 year after SARS-CoV-2 emergence leading to COVID-19 pandemic
KKW To, S Sridhar, KHY Chiu, DLL Hung… - Emerging microbes & …, 2021 - Taylor & Francis
Without modern medical management and vaccines, the severity of the Coronavirus
Disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome (SARS) …
Disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome (SARS) …
Emerging SARS-CoV-2 variants and impact in global vaccination programs against SARS-CoV-2/COVID-19
The emergence of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) variants
in different continents is causing a major concern in human global health. These variants …
in different continents is causing a major concern in human global health. These variants …
Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on covid-19 related symptoms, hospital admissions, and mortality in older adults in England …
Objective To estimate the real world effectiveness of the Pfizer-BioNTech BNT162b2 and
Oxford-AstraZeneca ChAdOx1-S vaccines against confirmed covid-19 symptoms (including …
Oxford-AstraZeneca ChAdOx1-S vaccines against confirmed covid-19 symptoms (including …
Assessing transmissibility of SARS-CoV-2 lineage B. 1.1. 7 in England
Abstract The SARS-CoV-2 lineage B. 1.1. 7, designated variant of concern (VOC) 202012/01
by Public Health England, was first identified in the UK in late summer to early autumn 2020 …
by Public Health England, was first identified in the UK in late summer to early autumn 2020 …
Resurgence of COVID-19 in Manaus, Brazil, despite high seroprevalence
Resurgence of COVID-19 in Manaus, Brazil, despite high seroprevalence - The Lancet Skip to
Main Content Advertisement The Lancet Journal This Journal Back Journal Home Online First …
Main Content Advertisement The Lancet Journal This Journal Back Journal Home Online First …
Risk of mortality in patients infected with SARS-CoV-2 variant of concern 202012/1: matched cohort study
Objective To establish whether there is any change in mortality from infection with a new
variant of SARS-CoV-2, designated a variant of concern (VOC-202012/1) in December …
variant of SARS-CoV-2, designated a variant of concern (VOC-202012/1) in December …
Genetic variants of SARS-CoV-2—what do they mean?
Over the course of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
pandemic, the clinical, scientific, and public health communities have had to respond to new …
pandemic, the clinical, scientific, and public health communities have had to respond to new …
mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants
Here we report on the antibody and memory B cell responses of a cohort of 20 volunteers
who received the Moderna (mRNA-1273) or Pfizer–BioNTech (BNT162b2) vaccine against …
who received the Moderna (mRNA-1273) or Pfizer–BioNTech (BNT162b2) vaccine against …
mRNA vaccination boosts cross-variant neutralizing antibodies elicited by SARS-CoV-2 infection
Emerging severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants have
raised concerns about resistance to neutralizing antibodies elicited by previous infection or …
raised concerns about resistance to neutralizing antibodies elicited by previous infection or …
Vaccination and non-pharmaceutical interventions for COVID-19: a mathematical modelling study
Background The dynamics of vaccination against SARS-CoV-2 are complicated by age-
dependent factors, changing levels of infection, and the relaxation of non-pharmaceutical …
dependent factors, changing levels of infection, and the relaxation of non-pharmaceutical …